|
CDR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.147930E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.741280E-03 |
| Normal-vs-Stage2 |
1.155380E-01 |
| Normal-vs-Stage3 |
5.904100E-02 |
| Normal-vs-Stage4 |
7.382200E-01 |
| Stage1-vs-Stage2 |
6.256400E-01 |
| Stage1-vs-Stage3 |
3.668000E-01 |
| Stage1-vs-Stage4 |
4.435300E-03 |
| Stage2-vs-Stage3 |
8.686800E-01 |
| Stage2-vs-Stage4 |
9.640400E-02 |
| Stage3-vs-Stage4 |
5.605900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.224250E-02 |
| Normal-vs-AfricanAmerican |
2.951600E-02 |
| Normal-vs-Asian |
6.475400E-01 |
| Caucasian-vs-AfricanAmerican |
3.450400E-01 |
| Caucasian-vs-Asian |
1.823360E-01 |
| AfricanAmerican-vs-Asian |
1.591760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.780100E-03 |
| Normal-vs-Female |
1.543970E-01 |
| Male-vs-Female |
2.496000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.258200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.303700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.940200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.452400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.193000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.249000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.378000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.849400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.482800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.731600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.378570E-03 |
| Normal-vs-Grade 2 |
3.169000E-04 |
| Normal-vs-Grade 3 |
4.760400E-01 |
| Normal-vs-Grade 4 |
6.550400E-01 |
| Grade 1-vs-Grade 2 |
2.669000E-01 |
| Grade 1-vs-Grade 3 |
3.824000E-02 |
| Grade 1-vs-Grade 4 |
5.311700E-02 |
| Grade 2-vs-Grade 3 |
1.976570E-03 |
| Grade 2-vs-Grade 4 |
1.977870E-02 |
| Grade 3-vs-Grade 4 |
9.419200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.673700E-02 |
| Normal-vs-ccB subtype |
4.494000E-02 |
| ccA subtype-vs-ccB subtype |
9.917200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.022400E-02 |
| Normal-vs-N1 |
2.974400E-01 |
| N0-vs-N1 |
7.306000E-02 |
|
|
